Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHA:600613)

SHA:600613 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	1,954	2,048	2,340	2,388	2,300	1,819
Other Revenue	0.51	0.51	0.68	0.22	2.92	0.38
Revenue	1,954	2,049	2,341	2,389	2,303	1,819
Revenue Growth (YoY)	-16.23%	-12.48%	-2.00%	3.72%	26.61%	-5.63%
Cost of Revenue	1,061	1,097	1,189	1,125	918.13	747.6
Gross Profit	893.61	951.71	1,152	1,263	1,385	1,071
Selling, General & Admin	735.61	784.63	1,002	1,097	1,232	1,008
Research & Development	31.58	32.89	32.3	45.99	50.95	42.79
Other Operating Expenses	23.41	24.58	26.51	29.62	27.22	21.55
Operating Expenses	810.79	858.28	1,025	1,178	1,294	1,183
Operating Income	82.81	93.43	126.37	85.79	90.69	-111.57
Interest Expense	-12.26	-12.8	-14.76	-17.37	-8.34	-4.94
Interest & Investment Income	10.56	10.85	5.97	8.17	30.51	1.96
Currency Exchange Gain (Loss)	-0.12	-0.12	0	0	-0	-0
Other Non Operating Income (Expenses)	-0.83	-1.19	11.79	-13.91	6.17	-67.71
EBT Excluding Unusual Items	80.15	90.17	129.37	62.69	119.03	-182.26
Impairment of Goodwill	-	-	-55.21	-	-	-162.08
Gain (Loss) on Sale of Investments	0.21	-0.02	0.9	-	-	-
Gain (Loss) on Sale of Assets	-0.52	-0.37	0.17	-5.23	-0	-1
Asset Writedown	-2.03	-1.47	-0.47	-2.72	-26.72	-0.13
Other Unusual Items	-1.46	-0.73	8.66	8.49	7.29	5.19
Pretax Income	76.35	87.58	83.41	63.23	99.6	-340.28
Income Tax Expense	19.67	21.5	25.15	14.93	31.64	13.19
Earnings From Continuing Operations	56.67	66.08	58.26	48.29	67.96	-353.47
Minority Interest in Earnings	5.77	5.31	-1.26	0.25	1.66	12.27
Net Income	62.44	71.39	57	48.55	69.62	-341.2
Net Income to Common	62.44	71.39	57	48.55	69.62	-341.2
Net Income Growth	9.24%	25.24%	17.41%	-30.27%	-	-
Shares Outstanding (Basic)	524	549	518	539	536	533
Shares Outstanding (Diluted)	524	549	518	539	536	533
Shares Change (YoY)	1.02%	5.97%	-3.94%	0.72%	0.46%	1.58%
EPS (Basic)	0.12	0.13	0.11	0.09	0.13	-0.64
EPS (Diluted)	0.12	0.13	0.11	0.09	0.13	-0.64
EPS Growth	8.14%	18.18%	22.22%	-30.77%	-	-
Free Cash Flow	89.44	171.39	191.08	292.59	98.3	2.79
Free Cash Flow Per Share	0.17	0.31	0.37	0.54	0.18	0.01
Dividend Per Share	0.150	0.150	0.100	0.100	0.100	-
Dividend Growth	50.00%	50.00%	-	-	-	-
Gross Margin	45.73%	46.45%	49.20%	52.90%	60.13%	58.90%
Operating Margin	4.24%	4.56%	5.40%	3.59%	3.94%	-6.13%
Profit Margin	3.19%	3.48%	2.44%	2.03%	3.02%	-18.76%
Free Cash Flow Margin	4.58%	8.37%	8.16%	12.25%	4.27%	0.15%
EBITDA	159.72	171.19	207.57	170.59	147.2	-58.69
EBITDA Margin	8.17%	8.36%	8.87%	7.14%	6.39%	-3.23%
D&A For EBITDA	76.9	77.76	81.2	84.8	56.51	52.88
EBIT	82.81	93.43	126.37	85.79	90.69	-111.57
EBIT Margin	4.24%	4.56%	5.40%	3.59%	3.94%	-6.13%
Effective Tax Rate	25.77%	24.55%	30.15%	23.62%	31.76%	-
Revenue as Reported	1,954	2,049	2,341	2,389	2,303	1,819
Advertising Expenses	-	-	-	-	-	399.83

Source: S&P Global Market Intelligence. Standard template. Financial Sources.